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Over the last few decades, medical research has started to emphasise the
need for an integrative approach that could unravel the progression of various
diseases across different spatial and temporal scales, and the links between
the different phases of disease progression [2, 6]. Among these diseases, the
fibroproliferative disorders are a leading cause of morbidity and mortality
by affecting tissues and organ systems [11], and thus investigating and un-
derstanding the common mechanisms behind fibrogenesis might lead to the
development of new therapies [9, 6].
In [1], the authors presented a brief review of the current state of the
art in mathematical modelling of various fibroproliferative disorders, with
an emphasis on the unified approach that needs to be taken when investi-
gating these disorders. While the need for an integrative, multi-scale and
multi-organ approach has been recognised by experimental scientists [8], the
amount and variety of information generated by basic research is still diffi-
cult to understand. To accelerate the development of clinical treatments for
fibrosis it is necessary not only to validate experimental models [10], but also
to derive and validate multi-scale mathematical models. As emphasised also
in [1], various single-scale fibrogenesis models (mainly described by ODEs
and PDEs) have been validated against patient data (usually microscale or
mesoscale data). Nevertheless, there are many other mathematical models
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that focus only on analytical approaches (equally important in the modelling
process to determine the appropriateness of model equations).
A particularly complex issue is the validation of multi-scale models, which
are being developed more and more often to investigate, for example, wound
healing [3, 7] or cancer dynamics [4]. Due to a lack of data – from same in
vitro or in vivo experiments – that links information regarding fibrogenesis
across scales, it is very difficult to validate these multi-scale mathematical
models. Moreover, because of data stochasticity, parameter sensitivity needs
to be performed to study the reliability of the model. The multi-scale aspects
of these models require the use of different sensitivity methods for different
mathematical equations (e.g., discrete or continuous) valid at different scales.
Hence, despite the great potential of these multi-scale models to provide a
unified description of the fibrosis process, their complexity combined with
a lack of serious model validation makes them currently unaccessible to ex-
perimental biologists and clinicians (who usually do not read journals that
present only abstract results).
Closer collaborations between mathematicians and experimentalists are
necessary to generate a comprehensive collection of uniform data (i.e., data
from patients with the same immune response against the same fibroprolifer-
ative disorder, and not from separate experimental studies performed under
different conditions), which could be then used for model calibration and
parameter estimation. It should be emphasised that current approaches fo-
cus mainly on collecting data existent the literature and generated through
different experimental conditions (see, for example, [5]). Such data is un-
likely to be of significant use for quantitative predictions, although it could
still generate qualitative predictions regarding the variety of responses that
might be observed in the biological system. Even if in vitro experiments are
specifically designed to validate specific multi-scale models, there is always
the possibility of observing discrepancies between the experiments and the
numerical results (as noticed in [7]), which challenges model assumptions and
requires the development of new experimental and modelling approaches to
address these discrepancies.
To conclude, testing the reliability of these multi-scale models is the first
step towards their use to propose quantitative and qualitative hypotheses
that could improve fibrosis treatments.
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